Uptake Medical makes safer emphysema therapy:
This article was originally published in Clinica
Executive Summary
Uptake Medical is developing a non-surgical technology to treat emphysema less invasively, which it says will be safer and more cost-effective than current surgery. Its catheter-based technique - bronchoscopic lung volume reduction (BLVR) - could provide an alternative to high-risk lung volume reduction surgery (LVRS).
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.